Nasus Pharma Ltd — All Filings
72 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
3
424B4
6-K
8-A12B
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
FWP
POS AM
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DRSLTR | — | 0001641172-25-011886 | May 21, 2025 | — |
| DRS/A | — | 0001641172-25-011885 | May 21, 2025 | — |
| UPLOAD | — | 0000000000-25-005395 | May 20, 2025 | — |
| DRSLTR | — | 0001641172-25-009588 | May 12, 2025 | — |
| DRS/A | — | 0001641172-25-009584 | May 12, 2025 | — |
| UPLOAD | — | 0000000000-25-004853 | May 7, 2025 | — |
| DRSLTR | — | 0001641172-25-006695 | Apr 29, 2025 | — |
| DRS/A | — | 0001641172-25-006692 | Apr 29, 2025 | — |
| UPLOAD | — | 0000000000-25-004261 | Apr 22, 2025 | — |
| DRSLTR | — | 0001641172-25-005111 | Apr 16, 2025 | — |
| DRS/A | — | 0001641172-25-005110 | Apr 16, 2025 | — |
| UPLOAD | — | 0000000000-25-003359 | Mar 28, 2025 | — |
| DRSLTR | — | 0001641172-25-000174 | Mar 21, 2025 | — |
| DRS/A | — | 0001641172-25-000173 | Mar 21, 2025 | — |
| UPLOAD | — | 0000000000-25-001867 | Feb 18, 2025 | — |
| DRS/A | — | 0001493152-25-005072 | Feb 6, 2025 | — |
| DRSLTR | — | 0001493152-25-005074 | Feb 5, 2025 | — |
| UPLOAD | — | 0000000000-25-000891 | Jan 28, 2025 | — |
| DRSLTR | — | 0001493152-24-052675 | Dec 31, 2024 | — |
| DRS/A | — | 0001493152-24-052673 | Dec 31, 2024 | — |
| UPLOAD | — | 0000000000-24-011017 | Sep 27, 2024 | — |
| DRS | — | 0001493152-24-034512 | Aug 30, 2024 | — |